Repro Med Systems, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 11/07/2017
Contact Info
  • 24 Carpenter Road
  • Chester, NY 10918

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0000704440
Fiscal Year End 2/28
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: NY, USA
Year of Inc. 1980
Employees 69 a/o Feb 28, 2017
Company Officers/Contacts
Andrew I. Sealfon CEO
Eric Bauer COO
Karen Fisher CFO, IR
Fred Ma CMO
Company Directors
Andrew I. Sealfon Chairman
David W Anderson
Paul Mark Baker
Joseph M Manko, Jr.
Mark Pastreich
Arthur J. Radin
Brad A. Sealfon
Company Notes
  • Sponsored for OTCQX by Salon Marrow Dyckman Newman & Broudy LLP on 9/18/2015
Service Providers
OTCQX Advisor
Not Available
Accounting/Auditing Firm
McGrail, Merkel, Quinn & Associates
Clay Avenue Professional Plaza
1173 Clay Avenue
Scranton, PA, 18510
United States

Legal Counsel
Salon Marrow Dyckman Newman & Broudy LLP
292 Madison Ave
6th Floor
New York, NY, 10017
United States

Investor Relations Firm
Not Available
REPR Security Details
Share Structure
Market Value1 $39,413,498 a/o Jan 22, 2018
Authorized Shares 50,000,000 a/o Jan 19, 2018
Outstanding Shares 40,758,529 a/o Jan 19, 2018
-Restricted 14,073,177 a/o Jan 19, 2018
-Unrestricted 26,685,352 a/o Jan 19, 2018
Held at DTC 20,140,552 a/o Jan 19, 2018
Float 21,159,887 a/o May 05, 2017
Par Value 0.01
Transfer Agent(s) Verified by Transfer Agent
Continental Stock Transfer & Trust Company
Shareholders of Record 841 a/o May 05, 2017
Short Selling Data
Short Interest 11,354 (27.02%)
Dec 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security